Medication First: Working In Missouri, Despite Stigma
For the first time since 1990, the U.S. experienced a drop in drug overdoses in 2018 – a modest 4-5% compared to 2017.
Erin Stringfellow, MSW, PhD is an Assistant Research Professor at the Missouri Institute of Mental Health, University of Missouri, St. Louis. She works with a dedicated, passionate team to conduct evaluation and research of federally-funded opioid-related grants. She specializes in applying qualitative and systems science methods to improving outcomes for people living with addictions. Her goal is to engage communities to develop sustainable interventions and policies that support recovery from addiction.
For the first time since 1990, the U.S. experienced a drop in drug overdoses in 2018 – a modest 4-5% compared to 2017.
Suboxone (buprenorphine/naloxone) is indicated for the treatment of opioid dependence in adults. Suboxone should not be taken by individuals who have been shown to be hypersensitive to buprenorphine or naloxone as serious adverse reactions, including anaphylactic shock, have been reported. Taking Suboxone (buprenorphine/naloxone) with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants can cause breathing problems that can lead to coma and death. Other side effects may include headaches, nausea, vomiting, constipation, insomnia, pain, increased sweating, sleepiness, dizziness, coordination problems, physical dependence or abuse, and liver problems. For more information about Suboxone (buprenorphine/naloxone) see Suboxone.com, the full Prescribing Information, and Medication Guide, or talk to your healthcare provider. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
All clinical and medical services are provided by licensed physicians and clinicians who are practicing as employees or contractors of independently owned and operated professional medical practices that are owned by licensed physicians. These medical practices include Workit Health (MI), PLLC, Workit Health (CA), P.C., Workit Health (NJ), LLC, Workit Health (OH), LLC, and any other Workit Health professional entity that is established in the future.
Arizona
9700 N. 91st. St.
Ste A-115
Scottsdale, AZ 85258
fax (HIPAA): (833) 664-5441
Florida
4730 North Habana Ave
Ste 206
Tampa, FL 33614
fax (HIPAA): (813) 200-2822
Michigan
3300 Washtenaw Ave
Ste 280
Ann Arbor, MI 48104
fax (HIPAA): (855) 716-4494
Montana
415 N Higgins Ave
Ste 6
Missoula, MT 59802
fax (HIPAA): (855) 716-4494
New Jersey
5 Greentree Center
Ste 117
Marlton, NJ 08053
fax (HIPAA): (609) 855-5027
New Mexico
5901 Indian School Road, NE
Ste 212
Albuquerque, NM 87110
fax (HIPAA): (855) 716-4494
Ohio
6855 Spring Valley Dr
Ste 110
Holland, OH 43528
fax (HIPAA): (513) 823-3247
Oklahoma
1010 24th Ave NW
Suite 100
Norman, OK 73069
fax (HIPAA): (855) 716-4494
Texas
8229 Shoal Creek Blvd
Ste 105
Austin, TX 78757
fax (HIPAA): (737) 738-5046
Clinic locations
Arizona
9700 N. 91st. St.
Ste A-115
Scottsdale, AZ 85258
fax (HIPAA): (833) 664-5441
Florida
600 Heritage Dr.
Ste 210, #17
Jupiter, FL 33458
fax (HIPAA): (813) 200-2822
Michigan
3300 Washtenaw Ave
Ste 280
Ann Arbor, MI 48104
fax (HIPAA): (855) 716-4494
Montana
415 N Higgins Ave
Ste 6
Missoula, MT 59802
fax (HIPAA): (855) 716-4494
New Jersey
5 Greentree Center
Ste 117
Marlton, NJ 08053
fax (HIPAA): (609) 855-5027
New Mexico
5901 Indian School Road, NE
Ste 212
Albuquerque, NM 87110
fax (HIPAA): (855) 716-4494
Ohio
6855 Spring Valley Dr
Ste 110
Holland, OH 43528
fax (HIPAA): (513) 823-3247
Oklahoma
1010 24th Ave NW
Suite 100
Norman, OK 73069
fax (HIPAA): (855) 716-4494
Texas
5373 W Alabama St
Ste 204
Houston, TX 77056
fax (HIPAA): (737) 738-5046
Discreet, flexible, and 100% online—Workit 90 is a recovery program that fits your life, giving you the tools you need to cut back or quit drinking.
This site uses cookies to improve your experience. By using this site, you consent to our use of cookies.